Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Engineering splicing factors with designed specificities.

Wang Y, Cheong CG, Hall TM, Wang Z.

Nat Methods. 2009 Nov;6(11):825-30. doi: 10.1038/nmeth.1379. Epub 2009 Oct 4.

2.

Pro-apoptotic effects of splice-switching oligonucleotides targeting Bcl-x pre-mRNA in human glioma cell lines.

Li Z, Li Q, Han L, Tian N, Liang Q, Li Y, Zhao X, Du C, Tian Y.

Oncol Rep. 2016 Feb;35(2):1013-9. doi: 10.3892/or.2015.4465. Epub 2015 Nov 30.

PMID:
26718027
3.

Bcl-x pre-mRNA splicing regulates brain injury after neonatal hypoxia-ischemia.

Xiao Q, Ford AL, Xu J, Yan P, Lee KY, Gonzales E, West T, Holtzman DM, Lee JM.

J Neurosci. 2012 Sep 26;32(39):13587-96.

4.

Regulation of alternative splicing of Bcl-x by BC200 contributes to breast cancer pathogenesis.

Singh R, Gupta SC, Peng WX, Zhou N, Pochampally R, Atfi A, Watabe K, Lu Z, Mo YY.

Cell Death Dis. 2016 Jun 9;7(6):e2262. doi: 10.1038/cddis.2016.168.

5.

Proteins associated with the exon junction complex also control the alternative splicing of apoptotic regulators.

Michelle L, Cloutier A, Toutant J, Shkreta L, Thibault P, Durand M, Garneau D, Gendron D, Lapointe E, Couture S, Le Hir H, Klinck R, Elela SA, Prinos P, Chabot B.

Mol Cell Biol. 2012 Mar;32(5):954-67. doi: 10.1128/MCB.06130-11. Epub 2011 Dec 27.

6.

SAP155 Binds to ceramide-responsive RNA cis-element 1 and regulates the alternative 5' splice site selection of Bcl-x pre-mRNA.

Massiello A, Roesser JR, Chalfant CE.

FASEB J. 2006 Aug;20(10):1680-2. Epub 2006 Jun 21.

PMID:
16790528
7.

Identification of a novel cis-element that regulates alternative splicing of Bcl-x pre-mRNA.

Lee J, Zhou J, Zheng X, Cho S, Moon H, Loh TJ, Jo K, Shen H.

Biochem Biophys Res Commun. 2012 Apr 6;420(2):467-72. doi: 10.1016/j.bbrc.2012.03.029. Epub 2012 Mar 13.

PMID:
22440396
8.

Chimeric peptide nucleic acid compounds modulate splicing of the bcl-x gene in vitro and in vivo.

Wilusz JE, Devanney SC, Caputi M.

Nucleic Acids Res. 2005 Nov 18;33(20):6547-54. Print 2005.

9.

Novel splicing factor RBM25 modulates Bcl-x pre-mRNA 5' splice site selection.

Zhou A, Ou AC, Cho A, Benz EJ Jr, Huang SC.

Mol Cell Biol. 2008 Oct;28(19):5924-36. doi: 10.1128/MCB.00560-08. Epub 2008 Jul 28.

10.

Anticancer drugs affect the alternative splicing of Bcl-x and other human apoptotic genes.

Shkreta L, Froehlich U, Paquet ER, Toutant J, Elela SA, Chabot B.

Mol Cancer Ther. 2008 Jun;7(6):1398-409. doi: 10.1158/1535-7163.MCT-08-0192.

11.

Long non-coding RNA INXS is a critical mediator of BCL-XS induced apoptosis.

DeOcesano-Pereira C, Amaral MS, Parreira KS, Ayupe AC, Jacysyn JF, Amarante-Mendes GP, Reis EM, Verjovski-Almeida S.

Nucleic Acids Res. 2014 Jul;42(13):8343-55. doi: 10.1093/nar/gku561. Epub 2014 Jul 3. Retraction in: Nucleic Acids Res. 2016 Nov 2;44(19):9518.

12.

Modification of alternative splicing of Bcl-x pre-mRNA in prostate and breast cancer cells. analysis of apoptosis and cell death.

Mercatante DR, Bortner CD, Cidlowski JA, Kole R.

J Biol Chem. 2001 May 11;276(19):16411-7. Epub 2001 Feb 7.

13.

TCERG1 regulates alternative splicing of the Bcl-x gene by modulating the rate of RNA polymerase II transcription.

Montes M, Cloutier A, Sánchez-Hernández N, Michelle L, Lemieux B, Blanchette M, Hernández-Munain C, Chabot B, Suñé C.

Mol Cell Biol. 2012 Feb;32(4):751-62. doi: 10.1128/MCB.06255-11. Epub 2011 Dec 12.

14.

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells.

Wei HH, Liu Y, Wang Y, Lu Q, Yang X, Li J, Wang Z.

J Vis Exp. 2017 Apr 26;(122). doi: 10.3791/54967.

PMID:
28518098
15.

Anti-tumor activity of splice-switching oligonucleotides.

Bauman JA, Li SD, Yang A, Huang L, Kole R.

Nucleic Acids Res. 2010 Dec;38(22):8348-56. doi: 10.1093/nar/gkq731. Epub 2010 Aug 18.

16.

Modification of alternative splicing of Bcl-x pre-mRNA in bladder cancer cells.

Zhu Z, Xing S, Cheng P, Zeng F, Lu G.

J Huazhong Univ Sci Technolog Med Sci. 2006;26(2):213-6.

PMID:
16850750
17.

E2F1 controls alternative splicing pattern of genes involved in apoptosis through upregulation of the splicing factor SC35.

Merdzhanova G, Edmond V, De Seranno S, Van den Broeck A, Corcos L, Brambilla C, Brambilla E, Gazzeri S, Eymin B.

Cell Death Differ. 2008 Dec;15(12):1815-23. doi: 10.1038/cdd.2008.135. Epub 2008 Sep 19.

18.

Amiloride modulates alternative splicing in leukemic cells and resensitizes Bcr-AblT315I mutant cells to imatinib.

Chang WH, Liu TC, Yang WK, Lee CC, Lin YH, Chen TY, Chang JG.

Cancer Res. 2011 Jan 15;71(2):383-92. doi: 10.1158/0008-5472.CAN-10-1037. Epub 2011 Jan 11.

19.

The transcription factor FBI-1 inhibits SAM68-mediated BCL-X alternative splicing and apoptosis.

Bielli P, Busà R, Di Stasi SM, Munoz MJ, Botti F, Kornblihtt AR, Sette C.

EMBO Rep. 2014 Apr;15(4):419-27. doi: 10.1002/embr.201338241. Epub 2014 Feb 10.

20.

Antagonistic effects of the SRp30c protein and cryptic 5' splice sites on the alternative splicing of the apoptotic regulator Bcl-x.

Cloutier P, Toutant J, Shkreta L, Goekjian S, Revil T, Chabot B.

J Biol Chem. 2008 Aug 1;283(31):21315-24. doi: 10.1074/jbc.M800353200. Epub 2008 Jun 5.

Supplemental Content

Support Center